The Obama administration may need to make still more changes to protect consumer privacy on the government's health insurance website.» Read More
NASH, or nonalcoholic steatohepatitis, is a liver disease that may affect as much as 12 percent of the U.S. population, Genfit's Dean Hum said.
Merck hoped to trump Gilead's hepatitis C treatment with its own shorter therapy, but early results show the four-week regimen may not be successful.
Did Obamacare have an inadvertent poison pill in there all along?
Arrowhead Research Chief Executive Chris Anzalone contends the company's hepatitis B therapy, ARC-520, has potential.
Craig Spencer, the New York City doctor who contracted Ebola, is being released from Bellevue Hospital Center, the NYT reports.
Apple's online store lists a lot of fitness-related products, but don't look for Fitbit.
In response to President Obama's proposal on broadband regulations, Ted Cruz tweeted on Monday that net neutrality is like Obamacare for the Internet.
The Supreme Court made the "right decision" to hear claims that financial aid to HealthCare.gov customers is illegal, a mastermind of the theory says.
Robots are joining doctors and scientists in combating the deadly Ebola outbreak.
Researchers, companies and Wall Street are gathering to gain a sense of bringing potentially multibillion dollar drugs to market.
Many customers shopping for Obamacare's most popular plans will see only modest increases—or even price cuts—on many of the cheapest plans.
To fast-track autism research, Google and scientists are using data analytics to find its roots and possible cures.
Weeks after Facebook's CEO gave $25 million to fight Ebola in Africa, his company is rolling out three initiatives to raise awareness and more money.
The U.S. FDA has revoked a tentative approval for India's Ranbaxy to make a cheap copy of AstraZeneca's heartburn drug Nexium.
Pascal Soriot, chief executive of AstraZeneca, said the U.S. had nearly removed the effect of tax inversion deals like Pfizer's bid for his company.
States that can benefit the most from Obama's health law elected officials who oppose the Affordable Care Act, report the New York Times.
The federal government wants large employers' insurance offerings to cover hospitalizations if they are to avoid Obamacare fines.
Want to know what's giving health stocks confidence in profit forecasts? Like it or not, it's the Affordable Care Act, aka Obamacare.
The Obama administration urged governors who haven't expanded their Medicaid programs to join 27 other states and Washington, D.C., in doing so.
A start-up has created technology it says can detect a variety of cancers with a device that can be used in a GP's surgery – or even at home.
Get the best of CNBC in your inbox